BPMX - BioPharmX Corporation

NYSE American - NYSE American Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Oct 2019)Next Qtr. (Jan 2020)Current Year (2020)Next Year (2021)
No. of Analysts2222
Avg. Estimate-0.16-0.16-0.83-0.65
Low Estimate-0.22-0.23-1.02-1.06
High Estimate-0.11-0.09-0.65-0.25
Year Ago EPS-0.5-0.25-2-0.83
Revenue EstimateCurrent Qtr. (Oct 2019)Next Qtr. (Jan 2020)Current Year (2020)Next Year (2021)
No. of Analysts2222
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago SalesN/A5k57kN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History10/30/20181/30/20194/29/20197/30/2019
EPS Est.-0.5-0.5-0.26-0.33
EPS Actual-0.5-0.25-0.38-0.22
Difference00.25-0.120.11
Surprise %0.00%50.00%-46.20%33.30%
EPS TrendCurrent Qtr. (Oct 2019)Next Qtr. (Jan 2020)Current Year (2020)Next Year (2021)
Current Estimate-0.16-0.16-0.83-0.65
7 Days Ago-0.16-0.16-0.83-0.65
30 Days Ago-0.22-0.23-1.05-1.06
60 Days Ago-0.22-0.23-1.05-1.06
90 Days Ago-0.25-0.27-1.05-1.05
EPS RevisionsCurrent Qtr. (Oct 2019)Next Qtr. (Jan 2020)Current Year (2020)Next Year (2021)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days1111
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesBPMXIndustrySectorS&P 500
Current Qtr.68.00%N/AN/A-0.01
Next Qtr.36.00%N/AN/A0.07
Current Year58.50%N/AN/A-0.01
Next Year21.70%N/AN/A0.14
Next 5 Years (per annum)N/AN/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A